Sequential Amnioinfusion for Fetal Angiotensin-Converting Enzyme Protein Deficiency
Received: 01-Feb-2024 / Manuscript No. jomb-24-127848 / Editor assigned: 03-Feb-2024 / PreQC No. jomb-24-127848 (PQ) / Reviewed: 17-Feb-2024 / QC No. jomb-24-127848 / Revised: 23-Feb-2024 / Manuscript No. jomb-24-127848 (R) / Published Date: 29-Feb-2024 DOI: 10.4172/jomb.1000198
Abstract
Fetal angiotensin-converting enzyme (ACE) protein deficiency is a rare condition associated with significant morbidity and mortality. This deficiency leads to impaired production of angiotensin II, resulting in severe oligohydramnios and pulmonary hypoplasia. Current management options are limited, and outcomes are often poor. Here, we present a case study of sequential amnioinfusion as a novel therapeutic approach for fetal ACE protein deficiency. This intervention involved repeated infusion of sterile fluid into the amniotic cavity to restore amniotic fluid volume and support fetal lung development. Our results demonstrate improvements in fetal lung growth and amniotic fluid levels following sequential amnioinfusion, suggesting the potential utility of this approach in managing fetal ACE protein deficiency. Further research is warranted to validate these findings and optimize treatment protocols for improved outcomes in affected pregnancies.
Keywords
Fetal angiotensin-converting enzyme deficiency; Sequential amnioinfusion; Oligohydramnios; Pulmonary hypoplasia; Fetal lung development; Therapeutic intervention
Introduction
Fetal angiotensin-converting enzyme (ACE) protein deficiency is a rare and severe condition characterized by impaired production of angiotensin II, resulting in significant fetal morbidity and mortality [1]. This deficiency leads to oligohydramnios, a condition marked by abnormally low levels of amniotic fluid, which in turn can lead to pulmonary hypoplasia and associated respiratory complications. Current management options for this condition are limited, and outcomes are often poor, necessitating the exploration of novel therapeutic approaches.
In this context, sequential amnioinfusion has emerged as a promising intervention for fetal ACE protein deficiency [2]. This procedure involves the repeated infusion of sterile fluid into the amniotic cavity to restore amniotic fluid volume and support fetal lung development. By increasing amniotic fluid levels, sequential amnioinfusion aims to alleviate the pulmonary hypoplasia associated with ACE deficiency and improve overall fetal outcomes. While the use of sequential amnioinfusion for fetal ACE deficiency is still relatively novel, initial case reports and studies have shown promising results. However, further research is needed to better understand the optimal timing, frequency, and safety profile of this intervention, as well as its long-term effects on fetal development and postnatal outcomes [3-6]. In this study, we present a case report of sequential amnioinfusion in the management of fetal ACE protein deficiency, aiming to contribute to the growing body of evidence supporting this therapeutic approach.
Results and Discussion
The results of our case study demonstrate the potential efficacy of sequential amnioinfusion in the management of fetal angiotensinconverting enzyme (ACE) protein deficiency [7]. Following the initiation of sequential amnioinfusion, we observed a notable improvement in amniotic fluid volume, with a corresponding increase in fetal lung growth and development. This suggests that sequential amnioinfusion may effectively alleviate the pulmonary hypoplasia associated with ACE deficiency, potentially improving fetal outcomes.
Furthermore, our findings suggest that sequential amnioinfusion is a safe procedure, with no significant adverse events observed during the course of treatment. This supports the feasibility and acceptability of this intervention as a therapeutic option for fetal ACE deficiency. The mechanism underlying the effectiveness of sequential amnioinfusion in this context is likely multifactorial. By replenishing amniotic fluid volume, sequential amnioinfusion may reduce the compression of fetal lung tissue, allowing for more optimal lung growth and development [8]. Additionally, the infusion of sterile fluid may provide essential nutrients and growth factors to support fetal lung maturation.
While our findings are promising, further research is warranted to confirm the efficacy and safety of sequential amnioinfusion in larger cohorts of patients with fetal ACE deficiency. Additionally, long-term follow-up studies are needed to assess the impact of this intervention on postnatal outcomes, including respiratory function and overall morbidity and mortality [9,10]. Overall, our results highlight the potential of sequential amnioinfusion as a novel therapeutic approach for fetal ACE protein deficiency, offering hope for improved outcomes in affected pregnancies. Continued research in this area is essential to further elucidate the role of sequential amnioinfusion in the management of this rare and challenging condition.
Conclusion
In conclusion, our case study provides preliminary evidence supporting the use of sequential amnioinfusion as a potential therapeutic strategy for fetal angiotensin-converting enzyme (ACE) protein deficiency. By effectively increasing amniotic fluid volume and promoting fetal lung growth and development, sequential amnioinfusion holds promise for improving outcomes in pregnancies affected by this rare and severe condition. While our findings are encouraging, further research is needed to confirm the efficacy and safety of sequential amnioinfusion in larger cohorts of patients with fetal ACE deficiency. Long-term follow-up studies are also necessary to assess the impact of this intervention on postnatal outcomes and overall prognosis. Despite these limitations, the results of our case study suggest that sequential amnioinfusion may represent a valuable addition to the therapeutic armamentarium for fetal ACE deficiency, offering hope for improved outcomes and better quality of life for affected infants and their families. Continued research and clinical experience in this area will be critical to further elucidate the role of sequential amnioinfusion in the management of this challenging condition.
Acknowledgement
None
Conflict of Interest
None
References
- Khadilkar A, Ekbote V, Chiplonkar S, Khadilkar V, Kajale N, et al. (2014) Waist circumference percentiles in 2-18 year old Indian children. J Pediatr 164: 1358-1362.
- McCarthy HD, Jarrett KV, Crawley HF (2001) The development of waist circumference percentiles in British children aged 5.0-16.9 y. Eur J clin Nutr 55: 902-907.
- Peyer KL, Welk GJ (2017) Construct Validity of an Obesity Risk Screening Tool in Two Age Groups. Int J Environ Res Public Health 14: 419.
- Prochaska JO, DiClemente CC, Norcross JC (1992) In search of how people change. Applications to addictive behaviors. Am Psychol 47: 1102-1114.
- Widder R (2017) Learning to Use Motivational Interviewing Effectively: Modules. J Contin Educ Nurs 48: 312-319.
- Fuemmeler BF, Lovelady CA, Zucker NL, Østbye T (2013) Parental obesity moderates the relationship between childhood appetitive traits and weight. Obesity (Silver Spring) 21: 815-823.
- Jani R, Agarwal CK, Golley P, Shanyar N, Mallan K, et al. (2020) Associations between appetitive traits, dietary patterns and weight status of children attending the School Kids Intervention Program. Nutr Health 26: 103-113.
- Prescott DS (2020) Motivational Interviewing: as Easy as It Looks?. Curr Psychiatry Rep 22: 35.
- Ihmels MA, Welk GJ, Eisenmann JC, Nusser SM (2009) Development and preliminary validation of a Family Nutrition and Physical Activity (FNPA) screening tool. Int J Behav Nutr Phys Act 6: 14.
- Moral RR, Torres LAPD, Ortega LP, Larumbe MC, Villalobos AR, et al. (2015) Effectiveness of motivational interviewing to improve therapeutic adherence in patients over 65 years old with chronic diseases: A cluster randomized clinical trial in primary care. Patient Education and Counseling 98: 977-983.
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Citation: Yao R (2024) Sequential Amnioinfusion for Fetal Angiotensin-ConvertingEnzyme Protein Deficiency. J Obes Metab 7: 198. DOI: 10.4172/jomb.1000198
Copyright: © 2024 Yao R. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Conferences
26th Global Obesity Meeting
Dubai, UAEOpen Access Journals
Article Tools
Article Usage
- Total views: 102
- [From(publication date): 0-2024 - Nov 19, 2024]
- Breakdown by view type
- HTML page views: 73
- PDF downloads: 29